Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
12/06/2024 Medicinal Product Shortages - update - 12 June 2024 Advisory
05/06/2024 Medicinal Product Shortages - update - 05 June 2024 Advisory
29/05/2024 Medicinal Product Shortages - update - 29 May 2024 Advisory
23/05/2024 Medicinal Product Shortages - update - 22 May 2024 Advisory
17/05/2024 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3rd Party Publications
15/05/2024 Medicinal Product Shortages - update - 15 May 2024 Advisory
08/05/2024 Medicinal Product Shortages - update - 08 May 2024 Advisory
01/05/2024 Product Information Update – Implanon NXT, 68 mg, implant for subdermal use (etonogestrel) 3rd Party Publications
01/05/2024 Medicinal Product Shortages - update - 01 May 2024 Advisory
24/04/2024 Medicinal Product Shortages - update - 24 April 2024 Advisory